VBIV - MCAP CO - VBI Vaccines Inc.

The market price visualization for VBI Vaccines Inc. (VBIV) demonstrates the dynamics of an asset valued at . The business relies on the development of hepatitis treatments, demonstrating resilience to crises and macroeconomic shocks. Possession of an advanced technological base and existing drug sales authorizations guarantee regular profits. Development within an autonomous cycle makes the company a reliable defensive asset with a constant inflow of investment.

The indicator's dynamics depend directly on the market's perception of the issuer's operational efficiency. This metric aggregates the value of all shares at the close of sessions, reflecting the balance between investment potential and risks. For VBI Vaccines Inc. (VBIV), this calculation is critical during its period of restructuring and the search for asset buyers. The current liquidity deficit makes the company's total market capitalization extremely volatile. Analyzing this curve allows for an assessment of the business's real resilience.